EC Status and Availability


EC knowledge among women of reproductive age: 19.6% (DHS 2010-11)

Contraceptive Use: 40.5% (DHS 2010-11, ever use of a modern method among women of reproductive age)

Registered LNG-EC products:

  • Postinor-2* - Available only with prescription
  • Pregnon - Available only with prescription
  • Revoke 1.5* - Available only with prescription
  • Revoke 72* - Available only with prescription

Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.

Where at least one type of ECP is available: Public sector clinics, Private clinics, Social marketing programs (eg PSI, DKT, MSI and PSIA)

Age restrictions for accessing ECPs: No data available

Legal/regulatory documents in which EC is included: National FP Norms, Essential Medicines List

Other relevant information: Zimbabwe's Essential Medicines List includes instructions on the Yuzpe regimen of EC, using combined oral contraceptives.

In Zimbabwe, the lowest cadre of health workers allowed to sell/dispense ECPs in the public sector is nurses. The lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is nurses. (Data as of 2013.) (USAID/DELIVER, Contraceptive Security Indicators, 2013)

In 2013, EC was procured by the government. No stock-outs were reported at the central level (JSI/Deliver data).

Our country-by-country information comes from numerous sources, including partners from around the world. We have made every effort to ensure that the information included here is correct, but EC availability and policies can change quickly. We welcome your additions and/or corrections

To submit updates and corrections to ICEC, click here.

Begin a new search